Metabolism - Clinical and Experimental
Volume 44, Issue 12 , Pages 1564-1569 , December 1995

Soluble receptors for tumor necrosis factor are markers for clinical course but not for major metabolic changes in human immunodeficiency virus infection

Received 19 November 1994 ,Accepted 17 March 1995.

References 

  1. Grunfeld C, Feingold KR. Metabolic disturbances and wasting in the acquired immunodeficiency syndrome. N Engl J Med. 1992;327:329–337
  2. Hommes MJT, Romijn JA, Godfried MH, et al.  Increased resting energy expenditure in human immunodeficiency virusinfected men. Metabolism. 1990;39:1186–1190
  3. Hommes MJT, Romijn JA, Endert E, et al.  Resting energy expenditure and substrate oxidation in human immunodeficiency virus (HIV)-infected asymptomatic men: HIV affects host metabolism in the early asymptomatic stage. Am J Clin Nutr. 1991;54:311–315
  4. Melchior JC, Salmon D, Rigaud D, et al.  Resting energy expenditure is increased in stable, malnourished HIV-infected patients. Am J Clin Nutr. 1991;53:437–441
  5. Grunfeld C, Pang M, Doerrler W, et al.  Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. J Clin Endocrinol Metab. 1992;74:1045–1052
  6. Hellerstein MK, Grunfeld C, Wu K, et al.  Increased de novo hepatic lipogenesis in human immunodeficiency virus infection. J Clin Endocrinol Metab. 1993;76:559–565
  7. Stein TP, Nutinsky C, Condoluci D, et al.  Protein and energy suhstrate metabolism in AIDS patients. Metabolism. 1990;39:876–881
  8. Kotler DP, Tierny AR, Wang J, et al.  Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr. 1989;50:444–447
  9. Chlebowski RT, Grosvenor MB, Bernhard NH, et al.  Nutritional status, gastrointestinal dysfunction, and survival in patients with AIDS. Am J Gastroenterol. 1989;84:1288–1293
  10. Tracey KJ, Cerami A. Tumor necrosis factor: An updated review of its biology. Crit Care Med. 1993;21:S415–S422
  11. Spiegelman BM, Hotamisligil GS. Through thick and thin: Wasting, obesity, and TNFα. Cell. 1993;73:625–627
  12. Fong Y, Moldawer LL, Marano M, et al.  Cachectin/TNF or IL-1α induces cachexia with redistribution of body proteins. Am J Physiol. 1989;256:R659–R665
  13. Warren RS, Starnes F, Gabrilove JL, et al.  The acute metabolic effects of tumor necrosis factor administration in humans. Arch Surg. 1987;122:1396–1400
  14. Van der Poll T, Romijn JA, Endert E, et al.  Tumor necrosis factor mimics the metabolic response to acute infection in healthy humans. Am J Physiol. 1991;261:E457–E465
  15. Sherry B, Gelin J, Fong Y, et al.  Anticachectin/tumor necrosis factor antibodies attenuate development of cachexia in tumor models. FASEB J. 1989;3:1956–1962
  16. Teng MN, Turksen K, Jacobs CA, et al.  Prevention of runting and cachexia by a chimeric TNF receptor-Fc protein. Clin Immunol Immunopathol. 1993;62:215–222
  17. Godfried MH, van tier Poll T, Jansen J, et al.  Soluble receptors for tumour necrosis factor: A putative marker of disease progression in HIV infection. AIDS. 1993;7:33–36
  18. Gehr G, Braun T, Lesslauer W. Cytokines, receptors, and inhibitors. Clin Invest. 1992;70:64–69
  19. Tartaglia LA, Goeddel DV. Two TNF receptors. Immunol Today. 1992;13:151–153
  20. Engelmann H, Aderka D, Nophar Y, et al.  Soluble and cell surface receptors for tumor necrosis factor. In:  van Furth R editors. Mononuclear Phagocytes. Dordrecht, The Netherlands: Kluwer Academic; 1992;p. 359–365
  21. Lantz M, Malik S, Slevin M, et al.  Infusion of tumor necrosis factor (TNF) causes an increase in circulating TNF-binding protein in humans. Cytokine. 1990;2:402–406
  22. Godfried MH, van der Poll T, Weverling GJ, et al.  Soluble receptors for tumor necrosis factor as predictors of progression to AIDS in asymptomatic human immunodeficiency virus-1 infection. J Infect Dis. 1994;169:739–745
  23. Centers for Disease Control . Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR. 1987;36:1S–14S
  24. Perkins KA, Epstein LH, Marks BL, et al.  The effect of nicotine on energy expenditure during light physical activity. N Engl J Med. 1989;320:898–903
  25. Engelberts I, Moller A, Schoen GJM, et al.  Evaluation of measurement of human TNF in plasma by ELISA. Lymphokine Cytokine Res. 1991;10:69–76
  26. Ferrannini E. The theoretical bases of indirect calorimetry: A review. Metabolism. 1988;37:287–301
  27. Ravussin E, Bogardus C. Relationship of genetics, age, and physical fitness to daily energy expenditure and fuel utilization. Am J Clin Nutr. 1989;49:968–975
  28. Altman DG. Practical Statistics for Medical Research. London, UK: Chapman & Hall; 1991;
  29. Kotler DP, Wang J, Pierson RN. Body composition studies in patients with the acquired immunodeficiency syndrome. Am J Clin Nutr. 1985;42:1255–1265
  30. Sluys TEMS, van der Ende ME, Swart GR, et al.  Body composition in patients with acquired immunodeficiency syndrome: A validation study of bioelectric impedance analysis. JPEN. 1993;17:404–406
  31. S:uttmann U, Selberg O, Gallati H, et al.  Tumour necrosis factor receptor levels are linked to the acute-phase response and malnutrition in human-immunodeficiency-virus-infected patients. Clin Sci. 1994;86:461–467
  32. Aukrust P, Liabakk NB, M:uller F, et al.  Serum levels of tumor necrosis factor-α (TNFα) and soluble TNF receptors in human immunodeficiency virus type 1 infection—Correlations to clinical, immunologic, and virologic parameters. J Infect Dis. 1994;169:420–424
  33. Tracey KJ, Wei H, Manogue KR, et al.  Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. J Exp Med. 1988;167:1211–1227

☆ T.V.D.P. is a fellow of the Royal Dutch Academy of Arts and Sciences.

PII: 0026-0495(95)90076-4

Metabolism - Clinical and Experimental
Volume 44, Issue 12 , Pages 1564-1569 , December 1995

Article Tools